DBIBB is a specific nonlipid agonist of the type 2 G protein coupled receptor for lysophosphatidic acid (LPA2). DBIBB mitigates the gastrointestinal radiation syndrome, increases intestinal crypt survival and enterocyte proliferation, and reduces apoptosis. DBIBB represents a agent candidate capable of mitigating acute radiation syndrome caused by high-dose gamma-radiation to the hematopoietic and gastrointestinal system[1].
Molekulargewicht:
452.48
Reinheit:
98.07
CAS Nummer:
[1569309-92-7]
Formel:
C23H20N2O6S
Target-Kategorie:
Apoptosis
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten